Clayface is entering its October 23 release with weak advance-ticket momentum compared with some recent genre competition. Current tracking places the DCU body-horror film roughly 80% behind Supergirl at the same point before release and 66% behind Resident Evil. A domestic opening near $20 million is the projection attached to that early sales picture, versus approximately $38 million for Supergirl in its US opening weekend.
That is an undeniably soft comparison for a movie carrying the DC brand. But it is not, on its own, proof that Clayface is headed for failure. The key distinction is scale: the film reportedly cost $40 million, rather than being mounted as one of the giant summer superhero spectacles associated with the biggest comic-book releases. A movie’s commercial target is tied to its costs and eventual worldwide run, not simply whether its first weekend matches a more expensive franchise counterpart.
What the pre-sale numbers do—and do not—say
Pre-sales measure tickets purchased before a movie opens. They are useful because they show the level of early commitment from audiences, particularly for titles built around large fan bases and opening-weekend events. In this case, the gap to both comparison films suggests that Clayface is not currently commanding the same advance-buying urgency.
That matters. A projected $20 million domestic debut would be considerably more modest than the result cited for Supergirl, and it raises the stakes for the film’s reception after people actually see it. DC Studios will want the movie to find a stronger audience beyond the people who were ready to buy a ticket more than a week in advance.
Still, pre-sales are not total box office. They capture one behavior at one moment: purchasing early. They do not fully capture later purchases, walk-up business, or whether viewers recommend the film to friends after opening night. They also do not determine the worldwide total, which is particularly relevant when a film’s reported production budget is $40 million.
The more useful reading is therefore measured rather than apocalyptic: the opening outlook appears middling, but the economics and genre positioning give the film a different threshold for success than a huge DCU tentpole.
A superhero character framed as body horror
Clayface is not being positioned simply as another costumed adventure. The film follows Matt Hagen, played by Tom Rhys Harries, an actor who is disfigured and then cursed with the ability to turn his body into living clay. That premise places transformation itself at the center of the story: an ability that can be viewed as power, affliction, or both.
Body horror is a useful term here. It describes horror built around disturbing changes to the human body, loss of bodily control, or the unsettling instability of physical form. For a shape-shifting character such as Clayface, it is a natural route into the material, but it can also set different audience expectations from a broad, effects-driven superhero release.
That difference helps explain why advance sales may be an imperfect single measure. Horror audiences do not necessarily behave like audiences for a conventional superhero event, where fans can rush to secure premium seats long before the opening. A movie that leans into horror can have more room to grow once its tone, scares, and overall quality become clear through public reaction.
The comparison to 2026 breakout films Obsession and Backrooms points toward that possibility. Their relevance is not that Clayface is guaranteed to repeat their results; it is that a genre film can be backloaded. In box-office terms, a backloaded run means a movie sustains or builds attendance after its first weekend instead of doing most of its business immediately. Positive word of mouth is the potential engine for that kind of performance.
Why budget reshapes the conversation
The reported $40 million budget is the most important counterweight to the bleak pre-sale comparison. A $20 million domestic opening may sound small beside a $38 million opening for another DC title, but box-office outcomes cannot be judged responsibly by comparing opening-weekend revenue alone. The size of the investment changes the level of revenue a film needs to justify itself.
There is no supplied figure for marketing costs, distributor returns, or the eventual worldwide gross needed for profitability, so it would be inappropriate to draw a precise break-even line. But the basic implication is clear: a film made for less has a more attainable commercial path than a much larger production. If Clayface can perform respectably overseas, avoid a severe second-weekend collapse, and generate good audience discussion, it has meaningful room to outrun expectations.
That is why calling the early sales a disaster would overstate what the available data supports. They are a warning that the film is not opening with the initial heat of a major superhero crowd-pleaser. They are not a complete accounting of its eventual performance, its costs, or its ability to connect with horror viewers after release.
For broader comic-book context, the audience conversation around ensemble-event movies remains intense, as seen in recent discussion of Hawkeye and Avengers: Doomsday. Clayface, however, appears to be asking for a different kind of engagement: not necessarily a mass opening-night ritual, but interest in a character-driven horror story using a recognizable DC villain.
Matt Hagen’s power is also the movie’s central question
Harries has emphasized just how formidable Clayface can become. He argued that the character could defeat Batman because Clayface can become anyone or anything, then pointed to the moral and personal decision that follows once Matt gains control: what should those abilities be used for?
That framing gives the movie more than a simple monster premise. Matt begins as an actor whose body has been transformed by trauma and a curse. Shape-shifting then offers near-limitless potential, but also threatens identity itself. If he can impersonate anyone and become anything, the character’s conflict is not merely whether he can overpower a human opponent. It is whether he can retain purpose and agency after his own form becomes unstable.
Batman’s shadow is consequently relevant even if the film’s core is Matt Hagen’s story. Clayface’s supposed advantage is raw versatility: he can alter his appearance, deceive, and physically transform. Batman, by contrast, is traditionally a human hero without superpowers. Harries’ point is that a controlled Clayface presents a threat that cannot be assessed as an ordinary fight.
Yet the phrasing also identifies the dramatic limitation: once Matt gains control. The film’s suspense can logically come from the gap between possessing immense abilities and mastering them. The supplied premise supports a story about a man cursed by his transformation, not a character who arrives with every implication of that transformation already solved.
The result will depend on the post-opening conversation
The next meaningful signal will be whether viewers respond to the body-horror approach and recommend it. That response can influence later ticket sales in a way advance tracking cannot fully predict. If audiences see the film as a distinctive genre entry with a compelling lead performance from Rhys Harries, a modest start could become less important than its staying power.
Conversely, a lower opening leaves less margin for a muted reaction. Without strong word of mouth, the film may struggle to turn its lower-cost strategy into a robust theatrical run. The early numbers therefore make opening weekend important, but they make the days afterward arguably more important.
Clayface has a clear commercial challenge ahead of October 23. It also has a clearer opportunity than the pre-sale headlines suggest: prove that a DC character film can operate at a smaller scale, lean into horror, and find its audience through conversation rather than an immediate blockbuster rush.
